PSMA-IN-3

CAT: 0804-HY-149869Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-149869Size:1 Each
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
PSMA-IN-3 (compound 17) is a novel high-affinity PSMA inhibitor with an IC50 value of 13 nM. PSMA-IN-3 is suitable for developing an 18F-labeled radioligand for PET imaging of PSMA in prostate cancer[1].
CAS Number
[2941187-68-2]
UNSPSC
12352005
Target
PSMA
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/psma-in-3.html
Solubility
10 mM in DMSO
Smiles
FC1=CC=C(C=C1)/C=N/OCC(NCC(N[C@H](C(O)=O)CC2=CC=C(C=C2)OCC(N[C@H](C(NCCCC[C@H](NC(N[C@H](C(O)=O)CCC(O)=O)=O)C(O)=O)=O)CC3=CC=CC=C3)=O)=O)=O
Molecular Formula
C43H50FN7O15
Molecular Weight
923.89
References & Citations
[1]Gade NR, et al. N-Alkyl Carbamoylimidazoles as Versatile Synthons for the Synthesis of Urea-Based PSMA Inhibitors. ACS Med Chem Lett. 2023 Jun 9;14 (7) :943-948.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Popular Products